MediGene AG (MDGEF)
0.10
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
MediGene Cash and Short Term Investments (Quarterly)
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | 61.38M |
| September 30, 2019 | 65.97M |
| June 30, 2019 | 74.31M |
| March 31, 2019 | 62.37M |
| December 31, 2018 | 58.77M |
| September 30, 2018 | 51.49M |
| June 30, 2018 | 57.02M |
| March 31, 2018 | 60.39M |
| December 31, 2017 | 62.11M |
| September 30, 2017 | 65.46M |
| June 30, 2017 | 68.29M |
| March 31, 2017 | 51.39M |
| December 31, 2016 | 55.51M |
| September 30, 2016 | 49.00M |
| June 30, 2016 | 54.07M |
| March 31, 2016 | 52.77M |
| December 31, 2015 | 50.79M |
| September 30, 2015 | 56.67M |
| June 30, 2015 | 11.21M |
| March 31, 2015 | 14.12M |
| December 31, 2014 | 18.12M |
| September 30, 2014 | 21.08M |
| June 30, 2014 | 5.609M |
| March 31, 2014 | 9.952M |
| December 31, 2013 | 14.01M |
| Date | Value |
|---|---|
| September 30, 2013 | 15.78M |
| June 30, 2013 | 19.45M |
| March 31, 2013 | 21.41M |
| December 31, 2012 | 26.52M |
| September 30, 2012 | 28.62M |
| June 30, 2012 | 32.20M |
| March 31, 2012 | 13.48M |
| December 31, 2011 | 16.63M |
| September 30, 2011 | 20.63M |
| June 30, 2011 | 22.99M |
| March 31, 2011 | 26.68M |
| September 30, 2010 | 14.72M |
| June 30, 2010 | |
| March 31, 2010 | 11.07M |
| December 31, 2009 | 17.58M |
| September 30, 2009 | 14.15M |
| June 30, 2009 | 18.97M |
| March 31, 2009 | 22.10M |
| December 31, 2008 | 34.89M |
| September 30, 2008 | 41.92M |
| June 30, 2008 | 51.16M |
| March 31, 2008 | 59.60M |
| December 31, 2007 | 68.00M |
| September 30, 2007 | 77.59M |
| June 30, 2007 | 62.90M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| InflaRx NV | 181.23M |
| BioNTech SE | 16.89B |
| Immatics NV | 449.72M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |